XML 26 R15.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies (Tables)
6 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Schedule of exercisable share purchase warrants outstanding
      
      Weighted
      Average
   Number of  Exercise Price
   Shares  ($)
Balance, September 30, 2020    500,000    3.88 
Granted    60,000    12.00 
Exercised    (350,000)   4.19 
Balance, September 30, 2021    210,000    5.69 
Forfeited    (50,000)   12.00 
Balance, March 31, 2022    160,000    3.72 

Schedule of share purchase warrants outstanding
      
Number  Exercise Price  Expiry Date
 150,000   $3.17   May 6, 2024
 10,000   $12.00   April 21, 2026
 160,000         

Schedule of outstanding stock purchase options
               
        Weighted   Weighted    
        Average   Average Grant   Aggregate
    Number of   Exercise Price   Date Fair Value   intrinsic value
    Shares   ($)   ($)   ($)
  Outstanding, September 30, 2020       10,076,266       3.48               14,982,581  
  Granted       2,732,000       12.55       9.32          
  Forfeited       (55,834 )     3.04       2.43          
  Exercised       (1,421,529 )     2.89       2.43       24,446,305  
  Outstanding, September 30, 2021       11,330,903       5.74               140,132,451  
  Granted       300,000       15.16       10.19          
  Forfeited       (103,750 )     5.39       4.04          
  Exercised       (176,834 )     2.81       2.23          
  Outstanding, March 31, 2022       11,350,319       6.04               81,056,222  
  Exercisable, March 31, 2022       8,201,651       3.81               70,271,175  

Schedule Of Share-based Payment Arrangement, Option, Activity
                       
            Weighted            
Range of exercise       average   Weighted       Weighted
prices   Number of   remaining   average   Number of   average
                  outstanding       contractual       exercise       vested       exercise  
  From       To       options       life (in years)       price       options       price  
$ 0.92     $ 2.96       4,108,765       5.67       2.29       4,059,181       2.29  
$ 3.15     $ 4.80       2,097,500       5.85       3.30       1,822,500       3.30  
$ 5.04     $ 8.98       3,347,054       5.91       6.06       2,207,054       6.35  
$ 11.10     $ 17.03       500,000       8.03       13.53       67,916       12.62  
$ 18.11     $ 24.58       1,297,000       9.33       19.39       45,000       24.08  
                  11,350,319                       8,201,651          

Schedule of general and administrative expenses and research and development expenses
               
    Three months ended March 31,   Six months ended March 31,
    2022   2021   2022   2021
General and administrative   $ 1,577,831     $ 793,957     $ 3,249,557     $ 1,216,780  
Research and development     2,861,625       1,052,199       5,098,673       1,568,690  
Total stock-based compensation   $ 4,439,456     $ 1,846,156     $ 8,348,230     $ 2,785,470  

Schedule of weighted average assumptions for fair value of each option award
       
    2022   2021
Risk-free interest rate     1.40 %     0.64 %
Expected life of options (years)     4.90       5.64  
Annualized volatility     95.88 %     96.26 %
Dividend rate     0.00 %     0.00 %